Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Charles Brenner
University of Iowa, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
ChromaDex, Inc.
Equity Interest - Publicly traded entity (e.g., stock, stock option, or other ownership interest)
Since Dr. Brenner has equity in and receives payment for consulting from the company whose product is being evaluated, and receives royalties from the company for the product being evaluated, bias or influence could be introduced into the research. Based on this analysis, we have determined that the interests could directly and significantly affect the design, conduct, or reporting of the PHS-funded research, or have the appearance of doing so.
Post-Translational Crosstalk in Cardiac Sodium Channels and Arrhythmogenesis
PROJECT NARRATIVE The proposed research seeks to understand the regulatory role of post-translational modifications on the main cardiac sodium channel with the ultimate goal of exploring the therapeutic potential of manipulating these modifications. This research is relevant to public health because dysfunction of the main cardiac sodium channel contributes to arrhythmias and sudden cardiac death in many heart conditions, including Heart Failure and Ischemic Cardiomyopathy, among other leading causes of death in our nation. Therefore, the proposed research is directly relevant to the NIH?s mission that pertains to fostering research strategies and their clinical translation as a basis for protecting and improving health.
Filed on July 25, 2018.
Tell us what you know about Charles Brenner's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Charles Brenner”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Charles Brenner | University of Iowa | Conflict of Interest | ChromaDex, Inc. | $20,000 - $39,999 |
| Charles Brenner | University of Iowa | Conflict of Interest | ChromaDex, Inc. | $20,000 - $39,999 |
| Charles Brenner | University of Iowa | Conflict of Interest | ChromaDex, Inc. | $20,000 - $39,999 |
| Charles Brenner | University of Iowa | Conflict of Interest | ChromaDex, Inc. | $20,000 - $39,999 |
| Charles Brenner | University of Iowa | Conflict of Interest | ChromaDex, Inc. | $40,000 - $59,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.